Avyuct LLC, headquartered in Herndon, Virginia, specializes in AI and machine learning for medical imaging diagnostics, with a focus on neurovascular care. We build AI that helps clinicians see more in the scans they already take — detecting and localizing cerebral vessel occlusions on CT angiograms, including the distal, medium-vessel occlusions (DMVOs) that conventional AI frequently misses. By pinpointing these occlusions vessel by vessel, Avyuct supports faster, clearer reads and gives clinicians decision support that keeps them in control.
Building that detection capability led us to something larger: the Neurovascular World Model. Where today's tools stop at detecting disease once it appears, our physics-grounded world model reads the same routine scan to detect anomalies, quantify the blood flow and pressure a picture can't show, and predict how a patient's condition is likely to progress — the aneurysm likely to rupture, the narrowing likely to cause a stroke — before disease is visible. It is decision support, the radiologist always reviews and signs, and it is investigational today, not yet approved for clinical use. Our aim is to move stroke and vascular care from reaction to prevention — to see the stroke coming before it happens.